MedTrace Logo

Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

NCT00753662 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2011-09-13

No results posted yet for this study

Summary

The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H2 coil to prefrontal and parieto-temporal cortex to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.

Conditions

Interventions

DEVICE

1Hz TMS with H2 coil

1Hz TMS with H2 coil to prefrontal and parieto-temporal cortex

DEVICE

10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex

10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex

DEVICE

SHAM TMS with H2 coil

SHAM TMS with H2 coil to prefrontal and parieto-temporal cortex

Sponsors & Collaborators

  • Brainsway

    collaborator INDUSTRY

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Alissa Ash, Dr. · Tel-Aviv Sourasky Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753662 on ClinicalTrials.gov